ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

被引：0

作者：

Gopaluni, Seerapani ^{[1
]}

Goymer, Donna ^{[2
]}

McClure, Mark ^{[1
]}

Cahill, Hugh ^{[2
]}

Broadhurst, Elizabeth ^{[2
]}

Smith, Rona ^{[1
]}

Jayne, David ^{[1
]}

机构：

[1] Univ Cambridge, Cambridge, England

[2] Cambridge Univ Hosp NHS Trust, Cambridge, England

来源：

RHEUMATOLOGY | 2019年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

302

引用

页数：2

共 50 条

[41] A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
Xiujuan Wu
Peng Tang
Shifei Li
Shushu Wang
Yueyang Liang
Ling Zhong
Lin Ren
Ting Zhang
Yi Zhang
Nature Communications, 9
[42] A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
Wu, Xiujuan
Tang, Peng
Li, Shifei
Wang, Shushu
Liang, Yueyang
Zhong, Ling
Ren, Lin
Zhang, Ting
Zhang, Yi
NATURE COMMUNICATIONS, 2018, 9
[43] A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
Hickish, Tamas
Cassidy, Jim
Propper, David
Chau, Ian
Falk, Stephen
Ford, Hugo
Iveson, Tim
Braun, Michael
Potter, Vanessa
Macpherson, Iain R.
Finnigan, Helen
Lee, Chooi
Jones, Hilary
Harrison, Mark
EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3136 - 3144
[44] Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
Hallifax, Rob
Laskawiec-Szkonter, Magda
Dobson, Melissa
Gerry, Stephen
Miller, Robert F.
Harvey, John E.
Rahman, Najib
BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
[45] Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial
Patil, Vijay M.
Menon, Nandini
Chatterjee, Abhishek
Tonse, Raees
Choudhari, Amit
Mahajan, Abhishek
Puranik, Ameya D.
Epari, Sridhar
Jadhav, Monica
Pathak, Shruti
Peelay, Zoya
Walavalkar, Rutuja
Muthuluri, Hemanth K.
Krishna, Madala Ravi
Chandrasekharan, Arun
Pande, Nikhil
Gupta, Tejpal
Banavali, Shripad
Jalali, Rakesh
ECLINICALMEDICINE, 2022, 49
[46] Safety, pharmacodynamics, and activity of rituximab in patients with relapsing-remitting multiple sclerosis: a phase I, multicentre, open-label clinical trial
Bar-Or, A.
Calabresi, P.
Arnold, D. L.
Markowitz, C.
Shafer, S.
Kasper, L.
Waubant, E.
Gazda, S.
Fox, R.
Panzara, M.
Sarkar, N.
Agarwal, S.
Smith, C.
MULTIPLE SCLEROSIS, 2007, 13 : S165 - S166
[47] A PHASE II, OPEN-LABEL, SINGLE ARM TRIAL OF PEMBROLIZUMAB FOR REFRACTORY ATYPICAL AND ANAPLASTIC MENINGIOMA AND HEMANGIOPERICYTOMA
Yust-Katz, Shlomit
Amiel, Alexandra
Yust-Katz, Shlomit
Limon, Dror
NEURO-ONCOLOGY, 2021, 23 : 57 - 57
[48] Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
Vogelmeier, Claus F.
Gaga, Mina
Aalamian-Mattheis, Maryam
Greulich, Timm
Marin, Jose M.
Castellani, Walter
Ninane, Vincent
Lane, Stephen
Nunez, Xavier
Patalano, Francesco
Clemens, Andreas
Kostikas, Konstantinos
RESPIRATORY RESEARCH, 2017, 18
[49] EFFICACY OF BROMOCRIPTINE IN AN OPEN-LABEL THERAPEUTIC TRIAL FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
MCMURRAY, RW
WEIDENSAUL, D
ALLEN, SH
WALKER, SE
JOURNAL OF RHEUMATOLOGY, 1995, 22 (11) : 2084 - 2091
[50] Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
Claus F. Vogelmeier
Mina Gaga
Maryam Aalamian-Mattheis
Timm Greulich
Jose M. Marin
Walter Castellani
Vincent Ninane
Stephen Lane
Xavier Nunez
Francesco Patalano
Andreas Clemens
Konstantinos Kostikas
Respiratory Research, 18

← 1 2 3 4 5 →